Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.210
-0.490 (-13.24%)
At close: Feb 27, 2026, 4:00 PM EST
3.200
-0.010 (-0.31%)
After-hours: Feb 27, 2026, 6:49 PM EST
Organogenesis Holdings Employees
Organogenesis Holdings had 854 employees as of December 31, 2025. The number of employees decreased by 15 or -1.73% compared to the previous year.
Employees
854
Change (1Y)
-15
Growth (1Y)
-1.73%
Revenue / Employee
$660,619
Profits / Employee
$23,445
Market Cap
412.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Kamada | 420 |
| Evolus | 329 |
| Esperion Therapeutics | 304 |
| Ironwood Pharmaceuticals | 253 |
| Akebia Therapeutics | 181 |
| Aquestive Therapeutics | 142 |
ORGO News
- 1 day ago - Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue - GlobeNewsWire
- 9 days ago - Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 2 months ago - Organogenesis Announces Initiation of Biologics License Application for ReNu® - GlobeNewsWire
- 2 months ago - Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - GlobeNewsWire
- 2 months ago - Organogenesis: High-Tech Skin Substitute Company On Sale - Seeking Alpha
- 4 months ago - Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance - GlobeNewsWire